Alerus Financial’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.84K Hold
186
﹤0.01% 402
2025
Q4
$9.46K Sell
186
-185
-50% -$9.46K ﹤0.01% 354
2025
Q3
$20.6K Buy
371
+185
+99% +$10.8K ﹤0.01% 318
2025
Q2
$12.8K Buy
+186
New +$12.7K ﹤0.01% 346

Other funds holding NVO

Alerus Financial's NVO Position: Q1 2026 in Review

Alerus Financial held its Novo Nordisk (NVO) position steady in Q1 2026 at 186 shares worth $6.84K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Alerus Financial first reported a position in NVO in Q2 2025 and has held it in 4 quarters since. The position peaked at $20.6K in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Alerus Financial held 186 shares of Novo Nordisk worth $6.84K as of Q1 2026.
  • Alerus Financial left its Novo Nordisk share count unchanged in Q1 2026.
  • Novo Nordisk made up ﹤0.01% of Alerus Financial's portfolio in Q1 2026, its #402 holding.
  • Alerus Financial first reported a position in Novo Nordisk in Q2 2025 and has held it in 4 quarters since.
  • Alerus Financial's Novo Nordisk position peaked at $20.6K in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.